Clinical trial
TRIAD Burden of Illness Mucositis Study
NCT00336609 · TRIAD Burden of Illness, Other · Unknown status
Key facts
| NCT number | NCT00336609 |
|---|---|
| Title | TRIAD Burden of Illness Mucositis Study |
| Official title | Risk and Outcomes of Mucositis in Subjects Being Treated for Breast, Colorectal, Head and Neck, Non-Small Cell Lung Cancers or Non-Hodgkin's Lymphoma |
| Lead sponsor | TRIAD Burden of Illness, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Gastrointestinal Mucositis (Defined as Mucositis Involving the Mouth, Esophagus, or Small Intestine) |
| Enrollment | 1,600 |
| Start date | Nov 1, 2005 |
| Completion | May 1, 2007 |
| First posted | Jun 14, 2006 |
| Last update posted | Apr 20, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: